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A ‘new-look’ SAMJ
The SAMJ now sports an educational component, resembling the BMJ, 
NEJM and Lancet, by incorporating CME. A review article[1] introduces 
readers to this month’s subject matter on mental health and we include 
summaries of the additional articles that may be accessed online.
The clashing epidemics of HIV and TB
Francois Venter, one of South Africa (SA)’s foremost HIV scientists, 
reveals in our guest editorial just how far SA has progressed in 
controlling the epidemic since our ‘AIDS denialism’ days.
Progress, arguably, would have been yet greater had SA not had to 
contend with the two clashing epidemics of HIV and tuberculosis (TB).
The relationship between HIV and TB is bi-directional: TB is a 
catalyst in the progression of HIV and HIV infection is associated 
with an increased risk of developing TB. HIV infection alters the 
clinical presentation of TB such that TB progresses more rapidly and 
aggressively in HIV-positive individuals, making diagnosis difficult.
Extrapulmonary TB (EPTB) occurs in 20 - 70% of HIV-infected 
patients with TB and is most prevalent in the 25 - 44-year age group. 
Karstaedt[2] demonstrates that the most common sites of EPTB are 
the pleura, lymph nodes, bacteraemia, meningitis and peritonitis. 
Disseminated TB occurred in 25% of the patients in this study.
Sputum smears, which are the cornerstone of diagnosis in resource-
limited settings, are usually negative in HIV-associated TB, contributing 
to a delay in commencing treatment. Fine needle aspiration biopsy 
(FNAB) of accompanying lymphadenitis provides a means of easy 
access to diagnostic material in many of these pulmonary cases. With 
this approach, Razack et al.[3] were able to confirm mycobacterial 
lymphadenitis (bacterial confirmation) in 80% of patients. 
Of TB infections, 1% affect the spine. Yet, of patients treated for 
spinal TB, only 55% have a definitive laboratory diagnosis (dependent 
on the identification of the TB bacilli by Ziehl-Neelsen staining 
in bone biopsy specimens). Watt and Davis[4] stress that in patients 
with HIV, and more specifically AIDS, the histological changes can 
range from the classical caseating granulomas to a non-specific 
chronic inflammatory reaction without necrosis. Unexpectedly, the 
highest culture yield observed in their study came from samples 
showing non-necrotising chronic inflammatory changes and not 
from samples showing necrotising granulomas. Confirming the 
diagnosis histologically is but half the battle, as sensitivity to first-line 
drugs has still to be proven. 
SA has one of the highest worldwide incidences of multidrug-
resistant (MDR)-TB, owed significantly to HIV co-infection. Almost 
a quarter of patients requiring treatment of their MDR-TB have 
symmetrical symptomatic peripheral neuropathy (SSPN) as the 
study by Conradie et al.[5] confirms. To avoid renal failure in such 
patients, due to the combined nephrotoxicity of aminoglycosides and 
tenofovir, stavudine is often used. Exposure to stavudine is a well-
documented risk factor for SSPN and Conradie et al. warn that the 
use of twice-daily stavudine for 6 months could potentially result in 
the development or exacerbation of SSPN. 
Management of chronic pain
Chronic pain affects around one in five patients in primary care, 
occurring more frequently in older individuals, whose presentation 
is complicated by age-related physiological changes, comorbidities 
and multiple medications. Chronic pain impacts quality of life, yet 
may be difficult to manage, and sufferers are more likely to report 
anxiety or depression. 
The South African guideline for the use of chronic opioid therapy for 
chronic non-cancer pain (CNCP)[6] developed by a multi-disciplinary 
panel provides recommendations for patient selection and the use 
of opioids for CNCP. Appropriate patient selection is paramount, 
requiring a comprehensive physical and biopsychosocial assessment to 
establish the diagnosis and to guide management decisions.
Opioids are well accepted for the treatment of severe acute pain 
and chronic pain associated with cancer and at the end of life, but 
less is known about their efficacy and safety with long-term use for 
CNCP. Nevertheless, limited evidence indicates that they can be 
effective therapy for a carefully selected group of patients as part 
of a wider management plan focused on reducing disability and 
improving quality of life. 
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